Troubling news from Asia about treating enteric fever: a coming storm
In The Lancet Infectious Diseases, Amit Arjyal and colleagues report the results from their randomised clinical trial comparing gatifl oxacin with ceftriaxone for patients with uncomplicated enteric fever in Nepal. Their two main fi ndings are sobering. First, they suggest that fl uoroquinolones should...
שמור ב:
מחבר ראשי: | Ryan, Edward T |
---|---|
פורמט: | Technical Report |
שפה: | en_US |
יצא לאור: |
Lancet Infect Dis 2016
2016
|
נושאים: | |
גישה מקוונת: | http://103.69.126.140:8080/handle/123456789/817 |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
פריטים דומים
-
Gatifloxacin versus ceftriaxone for uncomplicated enteric fever in Nepal: an open-label, two-centre, randomized controlled trial
מאת: Arjyal, Amit, et al.
יצא לאור: (2016) -
Study on incidence of Nalidixic acid resistant Salmonella enterica serovar Typhi and Salmonella entrica serovar Paratyphi A and their antibiotic susceptibilities.
מאת: Giri, Shudij
יצא לאור: (2012) -
Control of yellow fever Field Guide
יצא לאור: (2005) -
Frequently asked questions on chikungunya fever
יצא לאור: (2013) -
Knowledge, attitude and practice regarding dengue fever among the healthy population of highland and lowland communities in central Nepal.
מאת: Dhimal, Meghnath Aryal, Krishna Kumar Dhimal, Mandira Lamichhane Gautam, Ishan Singh, Shanker Pratap Bhusal, Chop Lal Kuch, Ulrich
יצא לאור: (2014)